Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_assertion evidence source_evidence_literature NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_assertion SIO_000772 23497317 NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_assertion wasDerivedFrom befree-2016 NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_assertion wasGeneratedBy ECO_0000203 NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.
- befree-2016 importedOn "2016-02-19" NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.